Consolidated Balance Sheets - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Current Assets
Cash	$ 3,026,569	$ 7,538,312
Advances on research and development contract services	328,844	579,910
Prepaid insurance	372,350	364,536
Prepaid expenses	10,000	12,479
Total current assets	3,737,763	8,495,237
Total assets	3,737,763	8,495,237
Current Liabilities
Accounts payable and accrued expenses	360,662	104,786
Research and development contract liabilities		783,675
Accrued legal settlement	414,989
Warrant liability	55,751	1,659,468
Total current liabilities	831,402	2,547,929
Total liabilities	831,402	2,547,929
Commitments and Contingencies
Stockholders’ Equity
Preferred Stock, $0.001 par value per share; 20,000,000 shares authorized; none issued or outstanding at December 31, 2023 and 2022
Common stock, $0.001 par value per share; 100,000,000 shares authorized; 534,238 and 63,820 shares issued and outstanding at December 31, 2023 and 2022, respectively	534	64
Additional paid-in capital	83,814,785	77,907,471
Accumulated deficit	(80,908,958)	(71,960,227)
Total stockholders’ equity	2,906,361	5,947,308
Total liabilities and stockholders’ equity	$ 3,737,763	$ 8,495,237